Skip to main content
Annovis Bio, Inc. logo

Annovis Bio, Inc. — Investor Relations & Filings

Ticker · ANVS ISIN · US03615A1088 LEI · 549300IFBVI51FN3NJ32 US Professional, scientific and technical activities
Open in API
Filings indexed 290 across all filing types
Latest filing 2020-07-06 Director's Dealing
Country US United States of America
Listing US ANVS

About Annovis Bio, Inc.

https://www.annovisbio.com/

Annovis Bio, Inc. is a clinical-stage drug platform company that develops therapies for neurodegenerative diseases. The company's primary focus is on conditions such as Alzheimer's disease (AD) and Parkinson's disease (PD). Its lead product candidate, buntanetap, is a translational inhibitor designed to halt the death of nerve cells by targeting the synthesis of multiple neurotoxic proteins. The company's therapeutic approach aims to restore nerve cell function, with the goal of improving cognitive and motor abilities in patients suffering from neurodegeneration.

Recent filings

Filing Released Lang Actions
4
Director's Dealing
2020-07-06 English
4
Director's Dealing
2020-07-06 English
4/A
Director's Dealing
2020-07-06 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated June 9, 2020. It announces a virtual corporate presentation by the CEO and CFO at an investor summit, including a press release and an investor presentation attached as exhibits. The text explicitly states that the presentation is attached and available on the company's website, and the document is relatively short (4373 characters). There are no detailed financial statements or substantive financial data included in the text itself. This matches the characteristics of a Regulatory Filing (RNS) as it is an announcement of events and exhibits rather than a full financial report or earnings release. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-06-09 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated June 3, 2020, by Annovis Bio, Inc. The key content is the submission of matters to a vote of security holders at the 2020 Annual Meeting of Stockholders. It details the election results of five directors and the ratification of the appointment of the independent registered public accounting firm. There are no financial statements or detailed financial data presented, only voting results. The document is about the official results from shareholder votes at a general meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4043 characters, which is consistent with a voting results announcement rather than a full report or presentation.
2020-06-05 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. It includes details about the Annual Meeting of Stockholders, voting instructions, and related materials. The document is titled 'Definitive Additional Materials' related to the proxy statement and includes information about the meeting date, voting procedures, and references to the Proxy Statement and Annual Report on Form 10-K. This type of document is classified as Proxy Solicitation & Information Statement (PSI) because it is intended to provide shareholders with information to solicit their votes for the annual meeting. The document length is 5526 characters, which is sufficient to contain substantive proxy solicitation information rather than just an announcement. Therefore, the correct classification is PSI with high confidence.
2020-06-01 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.